PTC Therapeutics, Inc.

PTC Therapeutics, Inc.verified

PTCT

Price:

$40.39

Market Cap:

$3.11B

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments for multiple therapeutic areas, such as rare diseases. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy in the European Economic Area and the United States, as well as to treat nonsense mutation Duchenne muscular dystrophy in Brazil and Russia; commercializes Tegsedi and Waylivra...[Read more]

Industry

Biotechnology

IPO Date

2013-06-20

Stock Exchange

NASDAQ

Ticker

PTCT

The Current Ratio as of November 2024 (TTM) for PTC Therapeutics, Inc. (PTCT) is 2.23

According to PTC Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.23. This represents a change of 20.70% compared to the average of 1.84 of the last 4 quarters.

PTC Therapeutics, Inc. (PTCT) Historical Current Ratio (quarterly & annually)

How has PTCT Current Ratio performed in the past?

The mean historical Current Ratio of PTC Therapeutics, Inc. over the last ten years is 4.10. The current 2.23 Current Ratio has changed 5.33% with respect to the historical average. Over the past ten years (40 quarters), PTCT's Current Ratio was at its highest in in the September 2014 quarter at 12.37. The Current Ratio was at its lowest in in the September 2023 quarter at 1.10.

Quarterly (TTM)
Annual

Average

4.10

Median

3.17

Minimum

1.52

Maximum

9.96

PTC Therapeutics, Inc. (PTCT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of PTC Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 71.76%

Maximum Annual Current Ratio = 9.96

Minimum Annual Increase = -65.81%

Minimum Annual Current Ratio = 1.52

Quarterly (TTM)
Annual
YearCurrent RatioChange
20232.0218.31%
20221.7112.48%
20211.52-65.81%
20204.4434.42%
20193.3071.76%
20181.92-36.63%
20173.04-42.35%
20165.27-32.86%
20157.84-21.29%
20149.96-9.77%

PTC Therapeutics, Inc. (PTCT) Average Current Ratio

How has PTCT Current Ratio performed in the past?

The current Current Ratio of PTC Therapeutics, Inc. (PTCT) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.75

5-year avg

2.60

10-year avg

4.10

PTC Therapeutics, Inc. (PTCT) Current Ratio vs. Peers

How is PTCT’s Current Ratio compared to its peers?

PTC Therapeutics, Inc.’s Current Ratio is less than Krystal Biotech, Inc. (7.97), less than Sarepta Therapeutics, Inc. (3.90), less than Iovance Biotherapeutics, Inc. (5.15), less than Madrigal Pharmaceuticals, Inc. (5.98), less than Reata Pharmaceuticals, Inc. (3.21), less than Intercept Pharmaceuticals, Inc. (4.22), less than Blueprint Medicines Corporation (3.32), less than Viking Therapeutics, Inc. (0), less than Hepion Pharmaceuticals, Inc. (36.47), less than null (5.62),

Build a custom stock screener for PTC Therapeutics, Inc. (PTCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PTC Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PTC Therapeutics, Inc. (PTCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PTC Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is PTC Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for PTC Therapeutics, Inc. (PTCT)?

What is the highest Current Ratio for PTC Therapeutics, Inc. (PTCT)?

What is the 3-year average Current Ratio for PTC Therapeutics, Inc. (PTCT)?

What is the 5-year average Current Ratio for PTC Therapeutics, Inc. (PTCT)?

How does the current Current Ratio for PTC Therapeutics, Inc. (PTCT) compare to its historical average?